Associate Director, Quality Systems and Compliance

Posted:
7/8/2026, 3:03:32 AM

Location(s):
New York, United States ⋅ New York, New York, United States

Experience Level(s):
Expert or higher ⋅ Senior

Field(s):
Legal & Compliance

Workplace Type:
Hybrid

Role Summary 

We are seeking an experienced Associate Director, Quality Systems & Compliance to lead strategic oversight and continuous improvement of our Quality Management System (QMS), Document Control for Policies, SOPs, Work Instruction & forms, and GxP as well as some non GxP Training programs. This individual will play a critical role in ensuring our quality infrastructure supports the development and commercialization of innovative gene therapies while maintaining compliance with applicable global regulatory requirements. 

The successful candidate will be a hands-on leader with extensive experience implementing and managing electronic quality systems, developing and maintaining controlled documentation, and administering enterprise-wide training programs within a biotechnology or pharmaceutical environment. 

About LEXEO 

Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.   

Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.

LEXEO Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment. 

 

Lexeo Therapeutics

Website: https://www.lexeotx.com/

Headquarter Location: New York, United States

Employee Count: 51-100

Year Founded: 2018

IPO Status: Public

Last Funding Type: Post-IPO Equity

Industries: Biotechnology ⋅ Life Science ⋅ Therapeutics

Visa Sponsorship: Sponsors work visas